Ms. Anne Poirier
Collaborator Spotlight:
Ms. Anne Poirier
Meet Klein Buendel’s newest research collaborator, Ms. Anne Poirier. She is the originator of the concept of body neutrality, which helps people step away from dieting and redefine their relationships with eating, their bodies, and themselves.
Ms. Poirier is the owner of a body neutrality coaching company and the author of books about self-care and compassion. She graduated from Plymouth State University with a bachelors’ degree in exercise science. She is also a graduate of the Eating Disorder Institute at Plymouth State University and the Life Coach Institute. She is an intuitive eating counselor, a self-talk trainer, and an NSCA-CSCS strength and conditioning specialist. She also serves on the National Eating Disorders Association Lived Experience Task Force.


Ms. Poirier is a nationally recognized body image expert and the author of The Body Joyful and Not a Fat Annie. She is a pioneer and leading voice for the body neutrality movement and has been featured and cited in major media outlets around the word including Shape, Women’s Health, New York Times, Washington Post, Newsy, Livestrong, ABC, and NPR. She is a long-time eating disorder survivor and certified self-talk trainer. She has been a guest on more than 50 podcasts. In 2015, she founded the company Shaping Perspectives…A Woman’s Way to Joy. The cornerstone of the company is the Body Joyful Solution, a coaching program based on the principles of body neutrality.
As her mission is to reduce bullying, body shaming, weight stigma, and eating disorders for the next generation, Ms. Poirier is collaborating with Klein Buendel Scientist, Dr. Kayla Nuss, on NoWeigh!, a novel approach to weight management. The NoWeigh approach emphasizes gratitude for the body’s function, a neutral attitude about the body’s appearance, and engagement in movement that is enjoyable, rather than weight loss. The NoWeigh! Project is funded by an SBIR grant from the National Institute of Diabetes, Digestive and Kidney Diseases (DK142209; Dr. Kayla Nuss, Principal Investigator).
